One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Saved in:
| Title: | One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. |
|---|---|
| Authors: | Bunck MC (AUTHOR), Diamant M (AUTHOR), Cornér A (AUTHOR), Eliasson B (AUTHOR), Malloy JL (AUTHOR), Shaginian RM (AUTHOR), Deng W (AUTHOR), Kendall DM (AUTHOR), Taskinen MR (AUTHOR), Smith U (AUTHOR), Yki-Järvinen H (AUTHOR), Heine RJ (AUTHOR), Bunck, Mathijs C1 (AUTHOR), Diamant, Michaela (AUTHOR), Cornér, Anja (AUTHOR), Eliasson, Bjorn (AUTHOR), Malloy, Jaret L (AUTHOR), Shaginian, Rimma M (AUTHOR), Deng, Wei (AUTHOR), Kendall, David M (AUTHOR) |
| Source: | Diabetes Care. May2009, Vol. 32 Issue 5, p762-768. 7p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
